Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • The cGAS-STING pathway: DNA sensing in health and disease (Jun 2026)
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Targeting lymphatic vessels enhances bone regeneration by augmenting osteoclast activity in mouse models of amputation
Neda Vishlaghi, Trisha K. Ghotra, Monisha Mittal, Ji Hae L. Choi, Sneha Korlakunta, Mingquan Yan, Janna L. Crossley, Danielle Griswold-Wheeler, Elnaz Ghotbi, Conan Juan, Shiri Gur-Cohen, Babak Mehrara, David A. Brown, Michael T. Dellinger, Lindsay A. Dawson, Benjamin Levi
Neda Vishlaghi, Trisha K. Ghotra, Monisha Mittal, Ji Hae L. Choi, Sneha Korlakunta, Mingquan Yan, Janna L. Crossley, Danielle Griswold-Wheeler, Elnaz Ghotbi, Conan Juan, Shiri Gur-Cohen, Babak Mehrara, David A. Brown, Michael T. Dellinger, Lindsay A. Dawson, Benjamin Levi
View: Text | PDF
Research Article Bone biology Vascular biology

Targeting lymphatic vessels enhances bone regeneration by augmenting osteoclast activity in mouse models of amputation

  • Text
  • PDF
Abstract

Although mammals generally demonstrate limited regenerative capacity compared with amphibians, the digit tip retains remarkable regenerative potential, providing a useful model to study successful mammalian regeneration. This process involves coordinated immune cell activity, vascular remodeling, and tissue reconstruction, yet the molecular checkpoints controlling regenerative versus fibrotic outcomes remain poorly understood. In mammals, regeneration of the digit tip (P3) proceeds through myeloid cell migration, early osteoclast-mediated osteolysis of the distal bone, and subsequent blastema-mediated regeneration. Here we test the hypothesis that lymphatic vessels regulate regenerative capacity by modulating local immune cell dynamics and osteoclast function. Using a lymphatic system–specific reporter line, we discovered that lymphatic vessels grow toward the nail region from the ventral side of the digit during quiescence and after amputation. These lymphatics closely surround, but do not invade, the native or regenerated bone. Unexpectedly, genetic, pharmacological, and surgical inhibition of lymphangiogenesis accelerated early osteolysis through enhanced transition of myeloid cells to osteoclasts, resulting in faster and more robust regeneration. These findings reveal a mechanism linking lymphatic vessel, immune regulation, and bone remodeling, suggesting that targeted manipulation of lymphatics dynamics may enhance regenerative outcomes after musculoskeletal injury.

Authors

Neda Vishlaghi, Trisha K. Ghotra, Monisha Mittal, Ji Hae L. Choi, Sneha Korlakunta, Mingquan Yan, Janna L. Crossley, Danielle Griswold-Wheeler, Elnaz Ghotbi, Conan Juan, Shiri Gur-Cohen, Babak Mehrara, David A. Brown, Michael T. Dellinger, Lindsay A. Dawson, Benjamin Levi

×

Figure 3

VEGFR3 inhibition enhances osteoclast-mediated bone resorption and accelerates bone remodeling during digit tip regeneration.

Options: View larger image (or click on image) Download as PowerPoint
VEGFR3 inhibition enhances osteoclast-mediated bone resorption and accel...
(A) Immunofluorescence staining for lymphatic markers PROX1 (green) and LYVE1 (red) in control and SAR131675-treated digits at 5 and 8 DPA. Scale bars, 100 μm. (B) Quantification of lymphatic vessel area (PROX1+LYVE1+) shows significantly decreased lymphangiogenesis in SAR131675-treated digits at 8 DPA. Data are mean ± SD; Student’s t test; *P < 0.05. (C) Representative longitudinal micro-CT renderings of control (top) and SAR131675-treated (bottom) digits from 5 to 42 DPA show accelerated histolysis followed by enhanced bone regeneration in SAR131675-treated samples. (D) Quantification of bone volume over time demonstrates greater initial bone resorption and earlier regeneration in the SAR131675-treated group (n = 4–12 digits per group; mean ± SD; *P < 0.05, **P < 0.01). (E–G) Violin plots comparing (E) Flt4 (VEGFR3) expression, (F) LEC score, and (G) osteoclast gene score between control and SAR131675-treated digits. VEGFR3 inhibition reduced lymphatic gene expression while increasing osteoclast-associated signatures. (H) TRAP-stained sections of distal P3 bone at 5 and 8 DPA show markedly elevated osteoclast activity (pink) in SAR131675-treated digits compared with controls. (I) Quantification of erosion perimeter/bone perimeter (μm) reveals significantly increased bone erosion in SAR131675-treated digits at 5 and 8 DPA. (J) Osteoclast number per bone perimeter (μm) is significantly higher in the SAR131675-treated group at 8 DPA. Data are mean ± SD; Student’s t test; *P < 0.05, ***P < 0.001, ****P < 0.0001.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts